Dr. Hans Peter Haselsteiner again appointed Authorised Representative of STRABAG SE
|
EQS-Ad-hoc: STRABAG SE / Key word(s): Personnel Dr. Hans Peter Haselsteiner again appointed Authorised Representative of STRABAG SE
The Management Board of STRABAG SE, with the approval of the Supervisory Board, has granted Dr. Hans Peter Haselsteiner general power of attorney with effect from today. In keeping with Klemens Haselsteiner’s vision, the Management Board will continue the far-reaching transformation process initiated under the title “Work On Progress”. During his tenure as CEO, Dr. Hans Peter Haselsteiner grew the company into an international group. He then continued to serve the Management Board in an advisory capacity as Authorised Representative until his son Klemens Haselsteiner took office on 1 January 2020. The foundation Haselsteiner Familien-Privatstiftung currently holds 30.7% of the shares of STRABAG SE. The Supervisory Board has already begun deliberating on a successor for the position of CEO. Until this position is filled, the remaining members of the Management Board will assume the responsibilities previously held by Klemens Haselsteiner. This will ensure the seamless continuation of these business areas and of the Management Board’s Strategy 2030: People. Planet. Progress. End of Inside Information
27-Jan-2025 CET/CEST News transmitted by EQS Group. www.eqs.com |
| Language: | English |
| Company: | STRABAG SE |
| Donau-City-Straße 9 | |
| 1220 Vienna | |
| Austria | |
| Phone: | +43 1 22422 – 1089 |
| Fax: | +43 1 22422 - 1177 |
| E-mail: | investor.relations@strabag.com |
| Internet: | www.strabag.com |
| ISIN: | AT000000STR1 |
| Listed: | Vienna Stock Exchange (Official Market) |
| EQS News ID: | 2075389 |
| End of Announcement | EQS News Service |
|
|
2075389 27-Jan-2025 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.